Chembio Historical Valuation

CEMI
 Stock
  

USD 0.85  0.01  1.16%   

Some fundamental drivers such as market cap or Chembio Diagnostics enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Chembio Diagnostics valuation indicators such as Average Assets of 53.1 M or Average Equity of 27.5 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Chembio Diagnostics's future value. Financial Statement Analysis is much more than just reviewing and breaking down Chembio Diagnostics prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chembio Diagnostics is a good buy for the upcoming year.
Continue to Trending Equities.
  

About Chembio Valuation Data Analysis

Valuation is the financial process of determining what Chembio Diagnostics is worth. Chembio Diagnostics valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Chembio Diagnostics valuation ratios help investors to determine whether Chembio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chembio with respect to the benefits of owning Chembio Diagnostics security.

Chembio Diagnostics Valuation Data Chart

Chembio valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of Chembio equity instrument and the benefits of owning shares of Chembio Diagnostics.
Chembio Diagnostics Invested Capital is most likely to increase significantly in the upcoming years. The last year's value of Invested Capital was reported at 52.03 Million. The current Invested Capital Average is estimated to increase to about 56.4 M, while Net Income Per Employee is projected to decrease to (103.3 K).

Average Assets

Average asset value for the period used in calculation of Return on Average Equity and Return on Average Assets; derived from Total Assets.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Chembio Diagnostics theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Chembio Diagnostics debt, but would also pocket its cash. Enterprise Value is more accurate representation of Chembio Diagnostics value than its market capitalization because it takes into account all of Chembio Diagnostics existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Market Capitalization

Market capitalization (or market cap) is the total value of the shares outstanding of Chembio Diagnostics. It is equal to Chembio Diagnostics current share price times the number of Chembio Diagnostics outstanding shares. Represents the product of [SharesBas]; [Price] and [ShareFactor].
Most indicators from Chembio Diagnostics valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into Chembio Diagnostics current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Chembio Diagnostics Invested Capital is most likely to increase significantly in the upcoming years. The last year's value of Invested Capital was reported at 52.03 Million. The current Invested Capital Average is estimated to increase to about 56.4 M, while Net Income Per Employee is projected to decrease to (103.3 K).
 2019 2020 2021 2022 (projected)
Enterprise Value83.16 M92.61 M24.17 M24.81 M
Average Equity27.21 M29.65 M30.14 M27.5 M

Chembio Diagnostics valuation accounts Correlations

Chembio Diagnostics Account Relationship Matchups

Chembio Diagnostics valuation accounts Accounts

201720182019202020212022 (projected)
Net Income Per Employee(38.62 K)(26.66 K)(42.21 K)(71.69 K)(100.6 K)(103.25 K)
Revenue Per Employee145.55 K113.25 K106.37 K91.22 K141.9 K153.21 K
Average Assets19.09 M31.75 M50.08 M66.01 M66.07 M53.11 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(5.18 M)(7.08 M)(11.41 M)(20.44 M)(28.12 M)(28.86 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(5.18 M)(7.08 M)(11.41 M)(20.44 M)(28.12 M)(28.86 M)
Earnings before Tax(6.46 M)(7.93 M)(14.18 M)(25.98 M)(33.97 M)(34.86 M)
Average Equity15.2 M24.7 M27.21 M29.65 M30.14 M27.5 M
Enterprise Value99.24 M90.84 M83.16 M92.61 M24.17 M24.81 M
Free Cash Flow(6.06 M)(13.25 M)(12.56 M)(22.85 M)(32.71 M)(33.57 M)
Invested Capital6.56 M13.38 M46.81 M45.26 M52.03 M56.14 M
Invested Capital Average8.74 M10.77 M38.03 M45.9 M52.23 M56.36 M
Market Capitalization101.01 M97.28 M80.1 M95.84 M34.25 M53.56 M
Tangible Asset Value13.35 M32.04 M45.94 M55.28 M70.23 M75.77 M
Working Capital7.76 M21.93 M25.78 M27.39 M39.95 M43.1 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chembio Diagnostics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving against Chembio Diagnostics

0.54ABCAmerisourcebergen Corp Fiscal Year End 3rd of November 2022 PairCorr
The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
25.7 M
Quarterly Revenue Growth YOY
0.42
Return On Assets
-0.3
Return On Equity
-2.06
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.